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Abstract
Transmissible gastroenteritis virus (TGEV) is a porcine coronavirus. Lithium chloride (LiCl) has been found to be effective
against several DNA viruses, such as Herpes simplex virus and vaccinia virus. Recently, we and others have reported the
inhibitory effect of LiCl on avian infectious bronchitis coronavirus (IBV) infection, an RNA virus. In the current study, the
action mechanism of LiCl on cell infection by TGEV was investigated. Plaque assays and 3-(4,5)-dimethylthiahiazo(-z-y1)-3,5-
di-phenyl tetrazoliumbromide (MTT) assays showed that the cell infection by TGEV was inhibited in a dose-dependent
manner, when LiCl was added to virus-infected cells; the cell infection was not affected when either cells or viruses were
pretreated with the drug. The inhibition of TGEV infection in vitro by LiCl was observed at different virus doses and with
different cell lines. The inhibitory effect of LiCl against TGEV infection and transcription was confirmed by RT-PCR and real-
time PCR targeting viral S and 3CL-protease genes. The time-of-addition effect of the drug on TGEV infection indicated that
LiCl acted on the initial and late stage of TGEV infection. The production of virus was not detected at 36 h post-infection
due to the drug treatment. Moreover, immunofluorescence (IF) and flow cytometry analyses based on staining of Annexin V
and propidium iodide staining of nuclei indicated that early and late cell apoptosis induced by TGEV was inhibited
efficiently. The ability of LiCl to inhibit apoptosis was investigated by IF analysis of caspase-3 expression. Our data indicate
that LiCl inhibits TGEV infection by exerting an anti-apoptotic effect. The inhibitory effect of LiCl was also observed with
porcine epidemic diarrhea coronavirus. Together with other reports concerning the inhibitory effect of lithium salts on IBV
in cell culture, our results indicate that LiCl may be a potent agent against porcine and avian coronaviruses.
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Introduction
Transmissible gastroenteritis virus (TGEV) belongs to the family
Coronaviridae and is one of the most important causative agents of
enteric infections in pigs. The infection is associated with high
morbidity in animals of all ages and with high mortality rates (up
to 100%) in seronegative suckling piglets [1-3]. TGEV is an
enveloped virus with a positive-stranded RNA genome approxi-
mately 28.5-kb in size, and it consists of four structural proteins:
the spike (S), the integral membrane (M) glycoprotein, and the
nucleocapsid (N) protein [1,4,5]. About two-thirds of the entire
RNA from the 59 end comprise open reading frames 1a and 1ab,
which encode a number of nonstructural proteins including the
replicase. The 39 third of the genome contains the genes encoding
the structural and some nonstructural proteins (59-S-3a-3b-E-M-
N-7-39) [6]. The glycoprotein S is primarily responsible for
inducing neutralizing antibodies and for initiating infection [7-9].
The appearance of porcine respiratory coronavirus (PRCoV), a
respiratory mutant of TGEV has drastically decreased the risk of
TGE in Europe, since neutralizing antibodies elicited by the
avirulent PRCoV can provide cross-protection against TGEV
infection [10]. In contrast, TGE prevalence is still reported and
some TGEVs have been isolated in different parts of the world,
e.g. in various geographical locations in China, implying that
TGEV infection is still threatening pig industry [11–14].
At present, several commercially available vaccines are
commonly used for prevention of TGEV infection in China.
However, current traditional inactivated and attenuated vaccines
are less effective than desired due to failure of vaccination to
prevent viral shedding or reversion of the attenuated to a virulent
phenotype. The lack of therapeutical treatment of TGE underlines
the importance of development of effective antivirals Lithium salts
have been used to treat diseases such as ’gout and rheumatic gout’,
’Bright’s disease’, epilepsy, syphilis, acute mania and depressive
episodes [15]. There are several reports regarding the inhibitory
effect of lithium salts on the replication of several DNA viruses,
such as type 1 and 2 herpes simplex virus and vaccinia virus
[15,16]. More recently, we and another research group demon-
strated that lithium chloride (LiCl) inhibits infection of cell cultures
by infectious bronchitis coronavirus (IBV), an avian coronavirus
[17,18].
The purpose of the current study was to investigate the action
mechanism concerning the inhibitory effect of LiCl on cell
infection by TGEV and to find out whether the susceptibility to
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LiCl on TGEV infection was analyzed by plaque assays, RT-PCR
and quantitative real-time PCR. The effect of the drug on
infection cycle of TGEV and virus production was assessed by
time-dependent drug addition. The inhibition of LiCl to cell
apoptosis caused by TGEV was demonstrated by immunofluo-
rescence and flow cytometry. The protective effect of LiCl to other
RNA viruses was also compared. Our data demonstrate that LiCl
may be a potent antiviral agent via an anti-apoptotic mechanism.
Methods
Cells and viruses
Swine testis (ST) cells and porcine kidney (PK-15) cells were
maintained in Eagle’s Minimum Essential Medium (EMEM).
Monkey kidney cell lines (Vero) and (MA 104) cells were cultured
in Dulbecco’s Modified Eagle Medium (DMEM). All the cells were
purchased from ATCC and kept in our laboratory. Cells were
cultured in respective medium supplemented with 10% newborn
bovine serum (NBS, Excell Bio. China) at 37uC in the CO2
incubator. TGEV strain PUR46-MAD was propagated in ST or
PK-15 cells. Porcine epidemic diarrhea virus (PEDV) isolate
HLJBY and Bovine rotavirus (BRV) strain NCDV were
propagated in Vero cells and MA104 cells, respectively.
Cytotoxic assay
Cytotoxic effect of lithium chloride, LiCl (Sigma, USA) on cell
viability was analyzed by trypan blue staining as previously
described [19]. Briefly, the cells in 6-well plates were incubated
LiCl serially diluted in serum-free EMEM (6 wells/each dilution)
for 48–72 h. After phosphate buffered saline (PBS) washing, the
cells were incubated with 0.5% w/v Trypan Blue Mix diluted in
PBS (1ml/well) at room temperature for 5 min followed by three
times washing with PBS. The percentage of viable cells was
calculated according to the equation: (Number of unstained cells/
Total number of cells)6100= Percentage of viable cells. The
effect of LiCl on cell proliferation was determined by 3– (4,5)-
dimethylthiahiazo (-z-y1) 23,5-di-phenytetrazoliumbromide
(MTT) assays. Briefly, cells in 96-well culture plates were washed
three times with PBS and incubated with LiCl serially diluted in
serum-free EMEM (6 wells/each dilution) for 48–72 h. Mock-
treated cells served as control. After washing with PBS, the cells
were incubated with medium (80 ml/well) and 0.5% MTT solution
(20 ml/well) at 37uC for 4 h. The cells were incubated with
dimethyl sulfoxide, DMSO (150 ml/well) and the tray was shaken
gently for 10 min, after washing with PBS. Optical density (OD)
value of the wells at a test wavelength of 570 nm was measured
using an ELISA reader. Cell survival rate was determined as drug
average OD value/control average OD value. The 50% cytostatic
concentration (CC50) was defined as the concentration that
inhibited the proliferation of exponentially growing cells by 50%
and non cytotoxic concentration (#CC50) of LiCl was used for
antiviral assays.
Virus titration and infection
For virus titration or infectivity analysis, plaque assays were
performed as previously described with modifications [18,20].
Briefly, cells seeded onto 24-well culture plates were inoculated
with serially diluted viruses. The inoculums were then replaced
with 1% (w/v) methylcellulose in EMEM (1 ml/well), after virus
absorption at 37uC for 1 h. Forty-eight hours later, the overlaid
medium was removed and the cells were rinsed three times with
PBS. Then they were fixed with 3% formalin in PBS (200 ml/well)
for 30 min at room temperature followed by staining with 1%
crystal violet (w/v) diluted in 5% ethanol in PBS (200 ml/well) for
20 min. The plaque number was recorded after complete washing
with PBS, and the virus titer in plaque-forming units (pfu) was
calculated. All infection assays were performed in 24-well culture
plates, unless otherwise indicated. Each assay was performed in
triplicate.
Antiviral activity of LiCl
To analyze the effect of LiCl on viruses, TGEV (1610
6 pfu/ml)
was incubated with serially diluted LiCl in medium at 37uC for
1 h. Then the viruses at an MOI (multiplicity of infection) of 0.3,
3, or 30 were used to infect cells in 24-well plates at 37uC for 1 h.
After washing three times with PBS, the cells were overlaid with
1% methylcellulose in medium and cultured for 48–72 h prior to
plaque assays as above. To analyze the impact of LiCl on cell, cells
in 24-well plates were treated with serially diluted LiCl in medium
at 37uC for 1 h. The cells were infected with TGEV at an MOI of
0.3, 3, or 30, after the cells were washed with PBS for three times.
Subsequently, the cells were overlaid with methycellulose for
plaque assays as above. To investigate the effect of LiCl on TGEV-
infected cells, cells in 24-well plates were washed with PBS for
three times and then infected with TGEV at an MOI of 0.3, 3, or
30 at 37uC for 1 h. Thereafter, the cells were washed with PBS
and incubated with serially diluted drugs at 37uC for 48–72 h. The
infectivity of the viruses was calculated with plaque assays as
above.
Impact of LiCl on TGEV-infected cells
To analyze the effect of LiCl on proliferation of cells infected
with TGEV, MTT colorimetric assays were performed [19,21,22].
Briefly, cells were plated in triplicate in 96-well plates. The cells
were incubated with TGEV at an MOI of 0.3, 3, or 30 at 37uC for
1 h. After washing with PBS, the cells were incubated with LiCl at
different concentrations at 37uC. Virus-infected and mock-treated
cells were infection and blank controls, respectively. At 48 h post-
infection (hpi), the cells were incubated with MTT solution (5 mg/
ml in PBS, 10 ml/well) at 37uC for 4 h. After washing with PBS,
the cells were incubated with DMSO and the OD570 value was
read as described above. Relative amount of survival cells (%) was
calculated as follows: Percent viable cells ={[OD of drug
treatment group-OD of infection control]/[OD of blank control-
OD of infection control]}6100%.
Reverse transcription-PCR
Reverse transcription (RT)-PCR was used to amplify (i) a partial
S gene designated as S-AD (encoding the major antigenic sites A
and D at the 59 end half of the TGEV S gene), (ii) a partial gene
comprising the 39half of the S gene, the intervening sequence and
the 3a gene (designated S-X), and (iii) a nonstructural gene
encoding the 3CLprotease (3CLpro). The housekeeping gene,
beta-actin was used as an internal reference. The information
regarding primer sequences and amplification products are
summarized in Table 1. TGEV-infected ST cells treated by LiCl
in 6-well plates were subjected to RNA extraction with a
commercial kit (Qiagen, Germany). Subsequent RT-PCR was
performed using a RT-PCR kit (TaKaRa, Japan). The PCR
profile for amplification of S-AD gene included 95uC for 10 min
and 30 cycles of 94uC for l min, 56uC for 1 min, 72uC for l min.
There was a final extension at 72uC for l0 min. The PCR for
amplification of TGEV S-X gene, 3CL protease gene and beta-
actin was performed as described for the S-AD gene except that
the annealing temperature were 47.6uC, 53uC and 58.8uC,
respectively. The PCR products were electrophoresed on 1%
agarose gel.
LiCl Inhibits Cell Infection by TGEV
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e18669Real-time RT-PCR
The effect of LiCl on cell infection by TGEV was confirmed by
real-time PCR targeting the S-X gene and 3CLpro gene of TGEV.
ST cells in 6-well plates were infected with TGEV at an MOI of 30
at 37uC for 1 h. The cells were treated with LiCl at different
concentrations at 37uC for 36–48 h, after washing with PBS. Then
the virus-containing culture was frozen and thawed three times
followed by addition of an equal volume of 20% polyethylene glycol
(PGE) 8000 at room temperature for 30 min. The samples were
centrifuged at 12000 rpm for 5 min and the pellets were
resuspended in RNase-free water. Then the total RNA was
extracted with a commercial kit (Fastgene, China) according to
the manufacturer’s instructions. The reverse transcription was
performed in total of 20 ml volume consisting of cDNA 5 ml, oligo
dTprimer1 ml,dNTP(10 mM)1 ml,RNAseinhibitor0.5 ml,sterile
water 7.5 ml, MLV 1 ml, 56RT-PCR buffer 4 ml. The reaction was
performed at 30uC for 10 min, 42uC for 60 min, and 95uC for
5 min. Subsequent real-time PCR was performed using ABI
PRISM 7500 real-time PCR machine (Applied Biosystems, USA).
The real-time PCR included 0.5 ml cDNA template, 10 ml SYBR
Taq polymerase, 0.4 ml ROX pge 2, 0.5 ml sense primer, 0.5 ml
antisense primer and 8.1 ml sterile water. The PCR parameters
included 95uC for 10 s; 40 cycles of 95uC for 5 s and 60uC for 34 s.
The expression level of TGEV S-X and TGEV 3CLpro was
normalized to that of beta-actin according to the comparative cycle
threshold (CT) method used for quantification recommended by the
manufacturer’s protocol. Delta CT was measured. The expression of
TGEV S-X and 3CLpro in TGEV-infected ST cells was
normalized to that of beta-actin and taken as 100% compared to
expression with drug treatments.
Data analysis is based on the measurement of the cycle
threshold (Ct). Isolated total DNA from untreated sample was
taken as reference. For each treated sample, the difference in gCt
(Ct sample fragment mean Ct value-beta-actin fragment mean Ct
value) was used as a measure of the relative fragment with the
2
2ggCt method [23,24] in correlation to the amplification size of
TGEV S-X or TGEV 3CLpro fragment. In brief, for the
quantification of the respective fragment in the treated samples,
real-time PCR analysis for the corresponding beta-actin fragments
was performed. For each experimental condition, real-time PCR
was conducted in quadruplicates and the resulting average of Ct
values for the TGEV X-S or TGEV 3CLpro fragment was used
for the evaluation of virus quantity. Therefore, the difference in
the gCt of untreated versus each treated condition of the
respective TGEV X-S or TGEV 3CLpro fragment was calculated
by the 2
2ggCt method expressed as ratio of the reduction for both
fragments. The experiment was performed in triplicate.
Time course of drug addition and virus production
The time-of-addition effect of LiCl on TGEV infection was
performed to analyze its mode of action. Cells in 96-well plates
were infected with TGEV at an MOI of 30. The cells were
incubated with LiCl at a concentration of 25 mM at 1 h intervals
starting at 1 h post infection (hpi). The infectivity of the viruses was
analyzed at the indicated time points using MTT assays by
measuring OD492 value of each well as above. In parallel, to
anazlye the effect of LiCl on virus production, the cells were
infected with TGEV at an MOI of 30 for 1 h followed by
incubation with serially diluted LiCl. Subsequently, the superna-
tants of the infected cells were collected at the indicated time
points and subjected to plaque assays.
Inhibition of other viruses
PEDV and BRV used to infect Vero and MA104 cells in 24-well
plates at 37uC for 1 h. Then the culture was kept at 37uC for 36–
Table 1. Information on primers and RT-PCR products.
Primer pairs
PCR product
in length
(bp)
Sense 59-GGGCGAATTCATGACTCTTGAAATTTCATGTTAT-39
Antisense 59-CCGGGTCGACTTTTATAACAGCTGTGGCATCTAA-39
TGEV S-
AD (734)
Sense 59-CTTAGTAGTAATATTTTGCATAC-39
Antisense 59-TATAGCAGATGATAGAATTAACA-39
TGEV S-X
(192)
Sense 59-ATGAAGGATGTCCTGGCAGTGT-39
Antisense 59-ACCACCGTACATTTCTCCTTCAAA-39
TGEV 3CLpro
(200)
Sense 59-GGCTCAGAGCAAGAGAGGTATCC-39
Antisense 59-GGTCTCAAACATGATCTGAGTCATCT-39
Beta-actin
(208)
doi:10.1371/journal.pone.0018669.t001
Figure 1. Cell viability analysis by trypan blue staining. The cell
viability of two cell lines (ST and PK) was evaluated with trypan blue
staining. Mock-treated cells and cells treated with the maximum non-
toxic concentration of LiCl were subjected to trypan blue staining and a
representative comparison is provided (A). The cell proliferation was
analyzed by MTT colorimetric assays. The cell survival rates at different
concentrations of drugs are given and 50% above cell survival rate (over
broken line) is regarded as non-toxic concentration of LiCl. Concentra-
tions 1 to 5 are 100, 50, 25, 20 and 10 mM for PK-15 cells respectively;
50, 30, 25, 20 and 15 mM for ST cells, respectively.
doi:10.1371/journal.pone.0018669.g001
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infectivity of both viruses was determined by plaque assays. The
assays were performed in triplicate.
Cell apoptosis analysis
Cell apoptosis was analyzed with Annexin V-FITC kit (Nanjing
Keygen Biotech, China) as previously described [18,19]. Briefly,
after the virus-infected cells had been treated with LiCl for 24 h, the
apoptotic cells were determined by fluorescence microscopy (Leica,
Germany) and the number of positive cells was calculated by
selection of five view fields. The effect of LiCl on caspase-3
expression on virus-infected cells was analyzed using immunoflu-
orescence (IF). The cells on 24-well plates were infected with TGEV
for 1 h. Then the cells were incubated with 25 mM LiCl after three
timeswashingwithPBS. Then thecellswere fixedwith4%formalin
in PBS followed by quenching with 0.1 M glycine in PBS. The cells
were incubated with specific rabbit anti-caspase-3 antibody (Beijing
Biosynthesis, China) for 1 h followed incubation with fluoresceine
isothiocyanate (FITC) conjugated goat anti-rabbit IgG (Zhongshan,
China)for1 h inthedark.Bothantibodieswere 1:100dilutedin1%
BSA.Thenucleiwerestainedwithpropidiumiodide(PI)for 15 min
in the dark prior to microscopic observation.
In parallel, flow cytometry was used to further analyze cell
apoptosis. Above-mentioned cell samples were trypsinized and
then centrifuged at 2000 rpm for 5 min. The cells were re-
suspended with 500 ml binding buffer at a concentration of 10
6
Figure 2. Protective effect of LiCl on TGEV infection of cultured cells. Increasing concentrations of LiCl were added to cells in 24-well plates
infected with TGEV at different MOI at 1 hpi. At 48 hpi, the yield of virus in the supernatant was determined by plaque assays. The inhibition rates
calculated from drug-treated ST and PK cells determined by plaque assays are shown in panels A and B, respectively. The effect of the infection was
also determined by MTT assays. The relative amount of survival cells were calculated as described in M&M. The result obtained with ST and PK cells is
shown in Panels C and D, respectively.
doi:10.1371/journal.pone.0018669.g002
Figure 3. Time-of-addition effect of LiCl on TGEV replication. Cells in 96-well plates were infected with TGEV at an MOI of 30 followed by
addition of 25 mM LiCl at the indicated time (hpi). The reduced virus titer was calculated using MTT assays by measuring OD492 value at 24 h post-
infection. The experiment was performed in triplicate.
doi:10.1371/journal.pone.0018669.g003
LiCl Inhibits Cell Infection by TGEV
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Then, 5 ml FITC-conjugated AnnexinV and 5 ml PI were added to
the cells and incubated at room temperature for 15 min in the
dark. The samples were analyzed within 1 h post-staining.
Comparative analysis of anti-apoptotic effect between
LiCl and pyrrolidine dithiocarbamate
The inhibitory effect of LiCl on cell apoptosis was compara-
tively analyzed with a caspase inhibitor, pyrrolidine dithiocarba-
mate (PDTC), a thiol reducing agent (Sigma, Beijing). Briefly, ST
cells in 24-well plate were treated with 850 mMo fH 2O2 alone, or
H2O2 (850 mM)+ PDTC (5 mM) or H2O2 (850 mM)+ LiCl
(25 mM) at 37uC for 4 h. The mock treated cells were used as
control. To analyze the inhibitory effect of PDTC and LiCl on
TGEV induced cell apoptosis, ST cells in 24-well plate were
infected with TGEV alone, TGEV+PDTC, or TGEV+LiCl at
37uC for 24 h. The mock-infected cells were used as control. The
titer of TGEV applied was at an MOI of 0.3 and the final
concentration of PDTC and LiCl was 5 mM and 25 mM,
respectively. The mock-treated cells were used as control. All
these cells were stained with Annexin V and PI and subjected to
immunofluorescence analysis as above.
Non-toxic concentration of LiCl
Staining with trypan blue showed that LiCl was non-toxic at
concentrations up to 25 mM. The viability rates of the two cell
lines analyzed, ST and PK cells, were above 95% and no
morphological differences were observed between drug-treated
and mock-treated cells at these concentrations (Figure 1). MTT
assays that determine the activity of a mitochondrial enzyme and
are commonly used to determine the proliferative activity of cells
showed that proliferation of ST and PK cells was not affected by
LiCl at concentrations below 25 mM (data not shown).
Pretreatment of viruses or cells does not result in
inhibition
To determine whether pretreatment of either cells or virus
affects the viral infectivity, cells or the TGEV inoculum were
treated with concentrations up to 25 mM of LiCl prior to
infection. Subsequent infection of either LiCl-treated cells with
untreated virus or untreated cells with LiCl-treated virus indicated
that there is no inhibitory effect regardless whether infection was
analyzed by plaque or MTT assays (data not shown).
LiCl inhibits cell infection by TGEV
LiCl decreased cell infection by TGEV, when virus-infected
cells were treated with LiCl. Plaque assays showed that some
inhibition was observed at 5 mM LiCl. A concentration of 25 mM
LiCl caused around 85% and 100% inhibition – depending on the
virus dose in ST cell lines (Figure 2A) and between 80 and 90%
inhibition in PK-15 cells (Figure 2B) infected by TGEV. The
results were confirmed by MTT assays (Figures 2C and 2D).
Although the inhibition of the virus at a higher MOI was slightly
lower, LiCl had a similar antiviral activity at MOIs in the range
from 0.3 to 30.
Time-of-addition effect of LiCl. The time-of-addition effect
of LiCl on the infection cycle of TGEV was analyzed. The results
showed that inhibition rates of 80% were observed when the drug
was added within the first 12 h p.i. (Figure 3). As shown in
Figure 4, the extent of inhibition by different concentrations of
LiCl was the same whether virus production was assayed at 32 or
40 h.p.i. Even at 48 h.p.i, the inhibitory effect of the drug to
TGEV-infected cells was still observed.
RT-PCR and real-time RT-PCR analysis of the inhibitory
effect of LiCl
The protective effect of LiCl on TGEV infection was confirmed
on the RNA level by conventional RT-PCR. Amplification of S-
AD (encoding the major antigenic sites A and D in the gene), S-X
(partial TGEV S gene together with a partial 3a gene including the
intervening sequence between both genes), and the gene for the
nonstructural 3CLprotease (3CLpro). Analysis of the TGEV-
RNAs indicated that the density of the product bands decreased
with increasing concentrations of LiCl (data not shown). The effect
of LiCl on the level of virus RNA was quantified by real-time RT-
PCR. The result demonstrated the dose-dependent decrease of the
amount of viral RNA synthesized in TGEV-infected cells. A major
reduction (more than 50%) in the relative amplification of both
Figure 4. Virus production of virus-infected cells. ST cells were
infected with TGEV at an MOI of 30 followed by incubation with serially
diluted LiCl. The supernatant of the infected cells were collected at the
different time points indicated and subjected to separate plaque assays.
doi:10.1371/journal.pone.0018669.g004
Figure 5. Quantitative measurement of TGEV 3CLpro and S-X
gene. Viral RNA was extracted from cell lysates with or without LiCl
treatment processed as described in M&M for real-time PCR. Reverse
transcription was performed and the delta Ct value was measured at
least in triplicate. The relative amplification of 3CLpro and TGEV-S-X in
TGEV-infected cells was normalized to that of beta-actin and calculated
using 2
2ggCt method. Displayed results are average of at least three
independent experiments.
doi:10.1371/journal.pone.0018669.g005
LiCl Inhibits Cell Infection by TGEV
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treated at a concentration of 5 to 25 mM of LiCl (Figure 5).
Antiviral activities of LiCl against other RNA viruses
To test whether LiCl also affects other RNA viruses, different
concentrations of LiCl were analyzed for their effect on the
infection by PEDV, another coronavirus, and by bovine rotavirus
(BRV). The former virus was analyzed in Vero cells (Figure 6A),
the latter virus in MA104 cells Figure 6B). The maximum non-
toxic concentrations of LiCl in these cells are 50 mM and
25 mM, respectively (13, 27, unpublished data). At these
concentrations, the infection was inhibited by more than 95%
(Figure 6).
LiCl inhibits TGEV-induced cell apoptosis
Apoptosis is a characteristic feature of TGEV-infected cells.
Therefore, we were interested whether LiCl is able to prevent the
apoptotic effect of TGEV. Apoptotic cells were visualized by
staining for annexin. As shown in Figure 7, counting the apoptotic
cells at 30 hpi. revealed that LiCl decreases TGEV-induced
apoptosis in a dose-dependent manner. Further quantification of
apoptotic cells was performed with flow cytometry. The results
showed that at 30 hpi, the early apoptosis of TGEV-infected cells
were significantly decreased after treatment with 25 mM LiCl. At
40 hpi, most cells were at a stage of late apoptosis, which was also
inhibited by drug treatment (Figure 8).
Caspase-3 is an enzyme involved in the apoptosis of cells. We
were interested to know, whether the antiapoptotic effect of LiCl
may be explained by inhibition of caspase-3. As shown in Figure 9
by immunofluorescence microscopy, the expression of caspase-3
was induced in TGEV-infected cells, but drastically reduced in
cells treated with LiCl. Like PDTC, LiCl was a potent apoptosis
inhibitor in terms of the inhibitory effect on cell apoptosis induced
by H2O2 (Figure 10A). Both agents also decreased the number of
apoptotic cells induced by TGEV effectively (Figure 10B).
Discussion
TGEV is an important pathogen in pigs, causing high mortality
in piglets. Generally, the SIgA in colostrum of sows vaccinated by
virulent or attenuated vaccine can provide effective protection to
Figure 6. Antiviral activities of LiCl against other RNA viruses. The inhibitory effect of LiCl on two other RNA viruses, PEDV and BRV, in
different cell lines was analyzed. The infectivity of PEDV and BRV was determined in Vero cells (A) and MA104 cells (B), respectively. The reduction of
virus titer is indicated in the y axis.
doi:10.1371/journal.pone.0018669.g006
Figure 7. Inhibitory effect of LiCl on cell apoptosis analyzed by
immunofluorescence. The cell apoptosis was analyzed after virus-
infected ST cells were treated with LiCl at different concentrations.
Mock-treated cells were used as control. The cells were stained with
FITC-conjugated Annexin V and the fluorescence signals were detected
under fluorescence microscope. The calculated apoptosis rate is
provided.
doi:10.1371/journal.pone.0018669.g007
LiCl Inhibits Cell Infection by TGEV
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prevalence of infectious agent in piglets remains. In addition to
enhancement of vaccine safety and efficacy, development of
potential antivirals is a complementary approach in the future
strategy for preventing TGEV infection. There are very limited
reports concerning anti-TGEV drugs and lack of effective
therapeutical treatment highlights the importance of identifying
appropriate antivirals. Recently, Yang et al. (2007) used
biochemical and virological methods to screen small-molecule
compounds that inhibit TGEV replication. The authors found a
series of benzothiazolium compounds that had inhibitory activity
against TGEV 3CLpro, one of the main proteases for the replicase
polyproteins in coronaviruses and these drugs exerted anti-TGEV
activities in terms of viral protein synthesis and RNA replication in
TGEV-infected ST cells [25]. More recently, LiCl was found to be
effective in preventing infection by IBV, an avian coronavirus, in
vitro [17,18]. The findings regarding the inhibitory effect of LiCl on
IBV are novel, because an inhibitory effect had been reported
previously only on several DNA viruses.
To see whether coronaviruses from different species have a
general susceptibility to LiCl treatment, we performed an
evaluation of the antiviral effect of LiCl on TGEV, a porcine
Figure 8. Cell apoptosis analysis by flow cytometry. The virus-infected cells were stained with Annexin V-FITC and PI, after they had been
treated with 25 mM LiCl. The cell apoptosis was analyzed by flow cytometry at either 30 or 40 h.p.i. The early and late apoptosis was quantified and
indicated in Q4 and Q1 gates, respectively. The apoptosis rates of cells are indicated.
doi:10.1371/journal.pone.0018669.g008
Figure 9. Expression of caspase-3 detected by immunofluorescence. The expression of caspase-3 on cells was analyzed using
immunofluorescence. ST cells on 24-well plates were infected with TGEV for 1 h. Then the cells were treated with LiCl for 40 h followed by incubation
with anti-caspase-3antibodyandFITC-conjugatedsecondaryantibody.Thenucleiwerestainedwithpropidiumiodidepriorto microscopicobservation.
doi:10.1371/journal.pone.0018669.g009
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infection in two cell lines (porcine kidney cell line, PK-15 and
swine testis cell line, ST). The inhibitory effect of LiCl was evident
both when the virus was titrated by plaque assay and when the
viability of the cells was determined by the MTT assay quantifying
mitochondrial dehydrogenase activities. In addition to TGEV
strain PUR46-MAD, a virulent TGEV isolate HBY was tested for
its sensitivity to LiCl and was found also to be affected by this
inhibitor (data not shown). At the same time, infection of different
cell lines by PEDV, another porcine coronavirus and bovine
rotavirus (PRV), a double-stranded RNA virus, were inhibited by
LiCl effectively. These data show that inhibition by LiCl may be a
general feature of some virus families, e.g. coronaviruses. In
addition, we found that LiCl did not directly interact with or
inactivate TGEV particles and was ineffective when pre-incubated
with host cells. In contrast, it inhibited plaque formation of virus-
infected cells. The results are consistent with the inhibitory effect
of LiCl on IBV. We therefore confirm our hypothesis that the
sensitivity of coronavirus to LiCl is a general feature of this virus
family.
It has been suggested that LiCl may act as an inhibitor of the
DNA virus herpes simplex virus [15]. Viral proteases play key roles
in virus replication and have been identified as potential targets in
the search for antiviral agents, e.g. for treatment of human
immunodeficiency virus or hepatitis C virus infections [25–28]. In
our study, the conventional RT-PCR targeting the 3CLpro and a
59 leader sequence of 3a gene in conjunction with the partial
TGEV S gene indicated that the effect of LiCl could be on RNA
transcription and replication. For IBV and TGEV coronaviruses,
it is also possible that LiCl inhibits RNA-dependent RNA
polymerases, which are characteristic of positive and negative-
stranded RNA viruses [17]. To further address the action of LiCl
on TGEV replication, the plaque formation and virus production
were quantified using time-of-addition assays during the infection
cycle of TGEV. Our results showed that LiCl inhibited TGEV
infection effectively when added as late as 12 h after the virus
inoculation, indicating that the inhibition of LiCl occurred during
the whole viral replication after infection. In our study, we used
different TGEV titers for cell infection and the inhibition of
TGEV by LiCl in vitro was titer-independent, which implies that
the drug also inhibits virus spread from cell to cell. The impact of
LiCl on TGEV load evaluated by real-time PCR further
confirmed its inhibition activity against TGEV.
Recently, the antiviral activity of quercetin 7-rhamnoside
against PEDV, another porcine coronavirus, has been analyzed.
Interestingly, the effectiveness of Q7R against TGEV and PRCV
(a respiratory variant of TGEV) was lower when compared to
PEDV [29]. This finding might suggest that some coronaviruses
differ in their susceptibility to the same drug. In our study, we
show that coronaviruses TGEV and PEDV are equally sensitive to
LiCl treatment; BRV, another RNA virus, showed a similar
sensitivity to the inhibitor. Our findings suggest a consistent
sensitivity of coronaviruses and some other RNA viruses to LiCl.
TGEV is the first coronavirus documented to trigger apoptosis in
infected cells [30]. Subsequently, infectious bronchitis virus (IBV)
[31], murine hepatitis virus (MHV) [32], severe acute respiratory
syndrome-associated coronavirus (SARS-CoV) [33], and equine
coronavirus [34] were found to have similar apoptotic effects. In
our study, we confirmed that TGEV infection induced the
appearance of apoptotic cells as shown by immmunofluorescence
Figure 10. Immunofluorescence assays of the inhibitory effect
of LiCl and PDTC on cell apoptosis. The cell apoptosis was induced
by H2O2 and the anti-apoptosis effect of LiCl was compared with a
caspase inhibitor, pyrrolidine dithiocarbamate (PDTC). ST cells in 24-well
plate were mock treated (cell control) or treated with 850 mMo fH 2O2
alone (H2O2 treated cells), or H2O2 (850 mM)+ PDTC (5 mM) (PDTC
treated cells) or H2O2 (850 mM)+ LiCl (25 mM) (LiCl treated cells) at 37uC
for 4 h followed by staining with Annexin V and PI and subjected to
immunofluorescence analysis (A). The inhibitory effect of both agents
on TGEV induced cell apoptosis was evaluated. ST cells in 24-well plate
were mock infected (Cell control) or infected with TGEV alone (TGEV
infected cells), TGEV+PDTC (5 mM) (PDTC treated cells), TGEV+LiCl
(25 mM) (LiCl treated cells) at 37uC for 24 h. The titer of TGEV applied
was at an MOI of 0.3 followed by Annexin V and PI staining and
subjected to immunofluorescence analysis (B). Green and red show the
early and late apoptotic cells, respectively.
doi:10.1371/journal.pone.0018669.g010
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cells were at a stage of late apoptosis at 40 h post-infection;
however, both early and late apoptosis of TGEV-infected cells was
inhibited by LiCl efficiently. Caspase-3, a member of the
aspartate-specific cysteinyl proteases or caspases has been
identified as being a key mediator of apoptosis of mammalian
cells [35]. In this study, the expression of caspase-3 was inhibited
after addition of LiCl to TGEV-infected cells. PDTC, a known
caspase inhibitor, was able to inhibit TGEV induced apoptosis
[30]. Interestingly, we found that LiCl also had a potent inhibitory
effect on TGEV-induced cell apoptosis. Apoptosis-associated
caspase activation of TGEV and SARS-CoV has been reported
[30,33]. We therefore anticipate that LiCl may have protective
effects on SARS-CoV induced infection and apoptosis. Taken
together, the data indicate that LiCl may inhibit TGEV infection
via exerting an anti-apoptotic effect mediated by caspase 3-related
pathways.
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